These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22676944)

  • 1. Association between leukocyte telomere length and drug-eluting stent strut coverage by optical coherence tomography.
    Armstrong EJ; Xing L; Zhang J; Zheng Y; Shunk KA; Yeh RW; Farzaneh-Far R; Yu B; Jang IK
    J Am Coll Cardiol; 2012 Jun; 59(24):2218-9. PubMed ID: 22676944
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Regar E; Nüesch E; Okamura T; Wykrzykowska J; di Mario C; Windecker S; van Es GA; Gobbens P; Jüni P; Serruys PW
    Circulation; 2011 Aug; 124(5):612-23. PubMed ID: 21768536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late stent thrombosis after sirolimus-eluting stent implantation observed using optical coherence tomography and coronary angioscopy.
    Ikenaga H; Dai K; Ishihara M
    J Invasive Cardiol; 2010 Nov; 22(11):557-8. PubMed ID: 21041855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings.
    Fujii K; Masutani M; Ohyanagi M
    Eur Heart J; 2008 Jun; 29(11):1385. PubMed ID: 18077442
    [No Abstract]   [Full Text] [Related]  

  • 6. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).
    Kim JS; Kim BK; Jang IK; Shin DH; Ko YG; Choi D; Hong MK; Cho YK; Nam CW; Hur SH; Choi JH; Song YB; Hahn JY; Choi SH; Gwon HC; Jang Y
    Am Heart J; 2012 Apr; 163(4):601-7. PubMed ID: 22520526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE study.
    Prati F; Stazi F; Dutary J; La Manna A; Di Giorgio A; Pawlosky T; Gonzalo N; Di Salvo ME; Imola F; Tamburino C; Albertucci M; Alfonso F
    Heart; 2011 Nov; 97(22):1841-6. PubMed ID: 21880655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography patterns of stent restenosis.
    Gonzalo N; Serruys PW; Okamura T; van Beusekom HM; Garcia-Garcia HM; van Soest G; van der Giessen W; Regar E
    Am Heart J; 2009 Aug; 158(2):284-93. PubMed ID: 19619707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
    Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
    J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.
    Guagliumi G; Costa MA; Sirbu V; Musumeci G; Bezerra HG; Suzuki N; Matiashvili A; Lortkipanidze N; Mihalcsik L; Trivisonno A; Valsecchi O; Mintz GS; Dressler O; Parise H; Maehara A; Cristea E; Lansky AJ; Mehran R; Stone GW
    Circulation; 2011 Jan; 123(3):274-81. PubMed ID: 21220730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe intimal hyperplasia after sirolimus eluting stent deployment: evaluation by optical coherence tomography.
    Gupta R; Raffel OC; Jang IK
    Heart; 2007 Jun; 93(6):754. PubMed ID: 17502657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation.
    Takano M; Xie Y; Murakami D; Inami S; Yamamoto M; Ohba T; Seino Y; Mizuno K
    Int J Cardiol; 2009 May; 134(2):263-5. PubMed ID: 18403032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence evaluation of everolimus-eluting stents 8 months after implantation.
    Inoue T; Shite J; Yoon J; Shinke T; Otake H; Sawada T; Kawamori H; Katoh H; Miyoshi N; Yoshino N; Kozuki A; Hariki H; Hirata K
    Heart; 2011 Sep; 97(17):1379-84. PubMed ID: 21051456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation.
    Motreff P; Souteyrand G; Levesque S; Ouchchane L; Dauphin C; Sarry L; Cassagnes J; Lusson JR
    Arch Cardiovasc Dis; 2009; 102(8-9):617-24. PubMed ID: 19786265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.